Logo (Actavis) 0303 Logo (Actavis) 0303 Pill: brown, capsule/oblong, 14mm
The pill with imprint Logo (Actavis) 0303 Logo (Actavis) 0303 (Brown, Capsule/Oblong, 14mm) has been identified as Dextroamphetamine Sulfate Extended-Release 5 mg and is used for ADHD, and Narcolepsy. It belongs to the drug class CNS stimulants and is classified as CSA Schedule 2 (High potential for abuse).
Images for Logo (Actavis) 0303 Logo (Actavis) 0303
Dextroamphetamine Sulfate Extended-Release
- Imprint
- Logo (Actavis) 0303 Logo (Actavis) 0303
- Strength
- 5 mg
- Color
- Brown
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Actavis Elizabeth LLC
- National Drug Code (NDC)
- 45963-0303
- Inactive Ingredients
-
ammonia,
ferrosoferric oxide,
medium-chain triglycerides,
oleic acid,
potassium hydroxide,
propylene glycol,
ferric oxide red,
shellac,
silicon dioxide,
sodium lauryl sulfate,
sucrose,
corn starch,
magnesium silicate,
titanium dioxide,
ferric oxide yellow,
alcohol,
butyl alcohol,
isopropyl alcohol,
water,
polyethylene glycol 400,
polyethylene glycol 8000
Note: Inactive ingredients may vary.
See also:
More about dextroamphetamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (298)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
- Dextroamphetamine drug information
- Dextroamphetamine Tablets
- Dextroamphetamine Sustained-Release Capsules
- Dextroamphetamine Oral Solution
Other brands
Dexedrine, Zenzedi, Xelstrym, ProCentra, ... +2 more
Professional resources
- Dextroamphetamine monograph
- Dextroamphetamine (FDA)
- Dextroamphetamine ER (FDA)
- Dextroamphetamine Extended-Release Capsules (FDA)
- Dextroamphetamine Oral Solution (FDA)
Other brands
Dexedrine, Zenzedi, Xelstrym, ProCentra, Dextrostat
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.